Otti Bengtsson Gref
Profile
Otti Bengtsson Gref worked as Director of Research & Development at Cavidi AB and Vice President of Research & Development at Biovica International AB.
She obtained an undergraduate degree from the University of Uppsala and a Master's in Business Administration from Mgruppen Svenska Managementgruppen AB.
Former positions of Otti Bengtsson Gref
Companies | Position | End |
---|---|---|
Cavidi AB
Cavidi AB Pharmaceuticals: MajorHealth Technology Cavidi AB develops and manufactures IVD tests for detection and monitoring of viral diseases. Its ExaVir product series utilizes the HIV reverse transcriptase enzyme to measure viral load and drug susceptibility. The company develops front-line assays for various polymerase enzymes of interest to pharmaceutical, medical, and veterinary research. It offers hospitals, private laboratories, pharmaceutical industries, and research institutions worldwide. Cavidi was founded in 1984 and is headquartered in Uppsala, Sweden. | Chief Tech/Sci/R&D Officer | - |
BIOVICA INTERNATIONAL AB | Chief Tech/Sci/R&D Officer | - |
Training of Otti Bengtsson Gref
University of Uppsala | Undergraduate Degree |
Mgruppen Svenska Managementgruppen AB | Masters Business Admin |
Experiences
Positions held
Linked companies
Listed companies | 1 |
---|---|
BIOVICA INTERNATIONAL AB | Health Technology |
Private companies | 1 |
---|---|
Cavidi AB
Cavidi AB Pharmaceuticals: MajorHealth Technology Cavidi AB develops and manufactures IVD tests for detection and monitoring of viral diseases. Its ExaVir product series utilizes the HIV reverse transcriptase enzyme to measure viral load and drug susceptibility. The company develops front-line assays for various polymerase enzymes of interest to pharmaceutical, medical, and veterinary research. It offers hospitals, private laboratories, pharmaceutical industries, and research institutions worldwide. Cavidi was founded in 1984 and is headquartered in Uppsala, Sweden. | Health Technology |
- Stock Market
- Insiders
- Otti Bengtsson Gref